TSANZ home

Results for "bronchiectasis"

Home 5 Search query for: bronchiectasis
Results for "bronchiectasis"
VOLUME 7.05 – JUNE 2022

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.05 – JUNE 2022

VOLUME 5.07 – DECEMBER 2020

Research Roundup:

December 2020

Welcome Message

Welcome to this month’s edition of our TSANZ Research Roundup.

This is a busy time for TSANZ and LFA’s research awards, with the Ann Woolcock New Investigator Award and LFA Ludwig Engel Research Award, Lizotte Family Research Award and Ivan Cash Research Awards currently under review. Keep your eyes open for several TSANZ awards opening soon! These will be accessible on the TSANZ Awards Submission Portal and include the new CFA Innovation Grant as detailed below. Also note NHMRC’s Special Initiative in Human Health and Environmental Change (SIHHEC). This will provide a catalytic stimulus to improve Australia’s current capability and capacity in human health and environmental change research, by supporting a single, multidisciplinary, nationally focused, collaborative network of researchers across Australia. The work of this network will help to protect the health of the Australian community and build a resilient and responsive health system. The focus includes improving current understanding of the complex interactions between primary, secondary and tertiary health effects of environmental and climate change.

Plans for our virtual ASM in 2021 are well underway, with registrations now open. Please visit our TSANZSRS2021 website for more details.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the December edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Janet Elder International Travel Award – closing 15 January 2021

Boehringer Ingelheim New Zealand COPD Travel Award – closing 15 January 2021

TSANZ Peter Phelan Research Grant – closing 27 January 2021

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closing 27 January 2021

Maurice Blackburn Occupational Lung Disease Grant-in-Aid – closing 27 January 2021

Lung Foundations Awards

Cochrane Airways Australia Scholarship – closing 4 December 2020

Cystic Fibrosis Australia Awards

Australian Cystic Fibrosis Research Trust 2021 Innovation Grant – closing 29 January 2021

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Cystic Fibrosis Innovation Grant

Cystic Fibrosis Australia (CFA) is pleased to announce the 2021 Innovation Grant for post- doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.

The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage.  Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data.  The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research.  The researcher will have completed a research higher degree in CF or a related area within the last ten years.

The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months.  In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

The maximum amount awarded under the Innovation Grant will be $80,000.  The actual amount provided will be subject to approval of the applicant’s budget.

Applications can be made through the website of The Thoracic Society of Australia & New Zealand (TSANZ) and must be received by TSANZ no later than 5.00 pm (AEDT) 29th January 2021.

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Respirology – Editor’s Choice

Respirology Issue 25.11 November 2020

 

Predictive value of control of COPD for risk of exacerbations: An international, prospective study

Marc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, Richard W. Costello, Victoria Carter, Jessica H.Y. Tan, Therese S. Lapperre, Bernardino Alcazar, Caroline Gouder, Cristina Esquinas, Juan Luis García-Rivero, Anu Kemppinen, Augustine Tee, Miguel Roman-Rodrígues, Juan José Solder-Cataluña, David B. Price and on behlaf of the Respiratory Effectiveness Group (REG)

 

Cover caption: Control in COPD is a tool to assess clinical patient status and decision making on step-up or down treatment. Uncontrolled status is associated with an increased risk of exacerbations. This is a collaborative international study of REG, a not-for-profit initiative established by international experts in real-life and comparative effectiveness research in respiratory medicine

DOI: 10.1111/resp.13811

 

Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study

Giacomo Sgalla, Erminia Lo Greco, Mariarosaria Calvello, Francesco Varone, Bruno Iovene, Stefania Cerri, Pierluigi Donatelli, Ada Vancheri, Mauro Pavone, Fabrizio Luppi, Carlo Vancheri and Luca Richeldi

 

Cover caption: The collaborative research team from three Italian centres in Catania, Rome and Modena. From left to right: Ada Vancheri, Carlo Vancheri, Bruno Iovene, Mauro Pavone, Giacomo Sgalla, Stefania Cerri, Francesco Varone, Luca Richeldi.

DOI: 10.1111/resp.13805

 

Respirology Issue 25.12 December 2020

 

 

Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic

David Langton, Joy Shia, Suzy Guo, Julie Sharp, Ceri Banks, Wei Wang, Virginia Plumber and Francis Thien

 

Cover caption:

Bronchial thermoplasty: Work in progress

DOI: 10.1111/resp.13830

 

Cost of hospitalisation for bronchiectasis exacerbation in children

Vikas Goyal, Steven M McPhail, Frank Hurley, Keith Grimwood, Julie M Marchant, I Brent Masters and Anne B Chang

 

Cover caption:

The emblem of AusBREATHE (Australian Bronchiectasis Centre of Research Excellence, especially for Aboriginal and Torres Strait Islander Children) is a reproduction of a painting by First Nations artist and former Menzies employee, who describes how the painting represents the lungs as follows:

‘When the earth was made, so were the first trees. They cleaned the air through their branches and leaves. The same is reflected in us with our lungs; they have branches like trees breathing in the air and cleaning our body and provide much needed oxygen.The butterflies represent a delicate balance; if something happens to the air, the butterflies will die. That’s why we must look after our air, like we have to look after our lungs because they keep us alive. The red dots represent alveoli that are at the end of the branches.’

DOI: 10.1111/resp.13828

Research Review

NZ Respiratory Research Review Issue 177

 

NZ Respiratory Research Review Issue 178

NZ Respiratory Research Review Issue 179

As part of an ongoing series focussing on new registrations in Australia, Research Review has released a product review of the use of beclometasone dipropionate/formoterol (Fostair) for patients with asthma.

This review discusses the evidence in support of the use of Fostair, its pharmacological properties, dosage and administration, and efficacy and tolerability as demonstrated in pivotal clinical trials. It also provides commentary and recommendations from Professor Francis Thien, Director of the Department of Respiratory and Sleep Medicine at Box Hill Hospital, Eastern Health, and the Monash University Clinical School in Melbourne, Australia.

 

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

VOLUME 7.05 – JUNE 2022

VOLUME 5.06 – SEPTEMBER 2020

Research Roundup:

September 2020

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. We hope that you remain well during this difficult time, and our thoughts are especially with our Victorian members who are on the front-line treating patients with COVID or facing unprecedented restrictions.

Plans for our exciting first virtual ASM in 2021 are well underway, with abstract submissions opened on 21 September 2020 and registrations opening on 22 October 2020. Please visit our TSANZSRS2021 website for more details about abstracts, and pay close attention to the closing date of 6 November 2020. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to be resubmitted for the 2021 Annual Scientific Meeting, and all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

The TSANZ Webinar Series continue, with the Society Medal and 50th Anniversary Medalpresentations on 30 September, so don’t forget to register for these exciting events.  

Please also note the opening of the following awards that are now accessible on the TSANZ Awards Submission Portal:

  • Past Presidents Scholarship Award: this new award will support national or international travel costs to present research for early career researchers who do not have the resources available to them via their institution or workplace. Importantly, the awardee will have the support from a TSANZ Past President who will provide invaluable feedback and professional development guidance to help them develop their research presentation skills.
  • Boehringer Ingelheim New Zealand Primary Care Grant: this award addresses the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.

In addition, we are pleased to announce the new CREATE PhD Scholarship, and the opening of LFA Awards:

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the September edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Call for Abstracts

Abstracts for TSANZSRS21 are now open. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to resubmit for the 2021 Annual Scientific Meeting. Please note, all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

Please submit your abstract by 6 November and join us for our first ever virtual ASM in 2021!

 

New Award: CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis

The CREATE PhD Scholarships in Pulmonary Fibrosis will support research into pulmonary fibrosis in Australia

Relevant domains of research inquiry include any form of clinical, population, laboratory, genetic or tissue based research. 

Students who are wishing to undertake a PhD, or are currently enrolled in a PhD in Pulmonary Fibrosis Research, are invited to submit an application. The student must be a resident in Australia throughout the period of the research program.

The Centre of Research Excellence in Pulmonary Fibrosis (the CRE-PF)  will allocate a total of two grants, each of $28,000, for the PhD Scholarships. These scholarships will either fund a stipend for one year for a full time student or may be extended over a second year, should the student be able to secure matching funds to permit extension of the period via their University or Research Institute. Extension of the funding in order to extend the value of the research investment by the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) and Lung Foundation Australia by securing matching funding from the host institution is encouraged and will be regarded favourably.

These funds are to be used for the student stipend. Direct, indirect research costs and/or infrastructure costs do not form part of this grant and will not be covered by this funding.

Click here for more info!

Open Awards

Thoracic Society Awards

TSANZ Past Presidents Scholarship Award – closing 04 October 2020

Boehringer Ingelheim New Zealand Primary Care Grant – closing 04 October 2020

TSANZ ASM 2021 abstract-linked Awards – closing 6 November 2020

 Lung Foundation Awards

Lizotte Family Idiopathic Pulmonary Fibrosis Research Grant – closing 13 October 2020

Ludwig Engel Grant-in-Aid for Physiological Respiratory Research – closing 13 October 2020

Ivan Cash Grant-in-Aid For Idiopathic Pulmonary Fibrosis Research – closing 13 October 2020

Cochrane Airways Australia Scholarship – closing 13 October 2020

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)

CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis – closing 31 October 2020

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Special Issue and Editor’s Choice
 

Respirology Issue 25.9 September 2020

 

Special Issue: Interventional Pulmonology Pearls

 

Cover caption: A collection of images from the Invited review series International Pumlonology Pearls.

Illustrations credit (A to F clockwise from top left) : A and B: Pyng Lee (personal communication), C and D: Fielding and Oki p.914, E: Guibert et al. p.953, F: Shah and Slebos p.972.

DOI: 10.1111/resp.13598

 

Respirology Issue 25.10 October 2020

 

Acute effects of e-cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma

Serafeim-Chrysovalantis Kotoulas, Athanasia Pataka, Kallipoi Domvri, Dionisios Sypratos, Paraskevi Katsaounou, Konstantinos Porpodis, Evangelia Fouka, Aikaterini Markopoulou, Katalin Passa-Fekte, Ioanna Grigoriou, Theodoros Kontakiotis, Paraskevi Argyropoulou and Despoina Papakosta

 

Cover caption: Asthmatic and healthy smokers underwent pulmonary function tests to assess acute effects of e-cigarettes

DOI: 10.1111/resp.13806

 

Peer Connect Service for people with pulmonary fibrosis in Australia: Participants’ experiences and process evaluation

Gabriella Tikellis, Joanna Y.T. Lee, Tamera J. Corte, Jamie Maloney, Michael Bartlett, Tonia Crawford, Ian N. Glaspole, Nicole Goh, Kelcie Herrmann, Alison J. Hey-Cunningham, Greg Keir, Yet H. Khor, John Price, Debra G. Sandford, Lissa Spencer, Alan Teoh, Jennifer Walsh, Susanne Webster and Anne E. Holland

 

Cover caption:  Bill, diagnosed with IPF in 2015, is a primary peer within the Pulmonary Fibrosis Peer Connect service. (Photograph credit: Lung Foundation Australia)

DOI: 10.1111/resp.13807

Invitations and surveys

BREATHE Study

Do you have asthma, emphysema, chronic bronchitis or bronchiectasis?

Do you live in an area affected by bushfires or bushfire smoke?

If yes to both, you may be eligible for the BREATHE study.

We are studying facemasks for prevention of smoke exposure

Find out more: https://kirby.unsw.edu.au/breathe

Please register your interest: https://www.surveymonkey.com/r/C96DXJN

Contact us: e.kpozehouen@unsw.edu.au

Ethics Approval: HC200477

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

 

VOLUME 7.05 – JUNE 2022

VOLUME 5.05 – AUGUST 2020

Research Roundup:

August 2020

.

Welcome Message

Welcome to the August Research Roundup. We hope you are all staying well in these uneasy COVID-19 times.

This month we are pleased to open two new awards. Firstly, we are very excited to announce and gratefully acknowledge the generous donation from our immediate past president, Prof Allan Glanville, to establish the Past Presidents Scholarship Award. We hope that others will join him in supporting this award that will provide both funding for our ECRs and, provide access to professional mentors and networks. Given global travel restrictions, ECRs are encouraged to think creatively when applying and consider the merit in visiting institutions closer to home.

Secondly, we would like to thank Boehringer Ingelheim New Zealand for supporting a new award for our New Zealand members. The Boehringer Ingelheim New Zealand Primary Care Grant aims to support research which will address the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic. Primary care can include general practice, allied health services, community health and community pharmacy.

As you would be aware, TSANZ is part of the National COVID-19 Clinical Evidence Taskforce; a living guideline which is continuously updated as new peer reviewed research becomes available. Many of our members are contributing to the COVID-19 research effort. One large multi-centre trial is the ASCOT trial (AustralaSian COVID-19 Trial) which many of our members are involved in. This trial will which be featured in a TSANZ webinar on 17 September 20.

We are pleased to again be hosting the LFA Awards. These will be opening on the 1st of September, including the Lizotte Family Research Award for IPF Research; Ludwig Engel Grant-in-Aid for Physiological Research; Ivan Cash Grant-in-Aid for IPF Research; and the Cochrane Airways Australia Scholarship. Please see below for more details.

As TSANZ members we also have the privilege of participating in an increasing number of surveys as detailed below. These include surveys of the Breathe Study: Investigating the role of masks for patients with asthma and COPD against bushfire smoke, Cystic Fibrosis Australia Research and Advocacy Priority Setting, and studies aimed at improving the quality of clinical trials evaluating  the management of COPD exacerbations, nurses’ attitudes to caring for people with intellectual disability, global current practices of mechanical ventilation management in COVID-19 patients, self-management for pulmonary fibrosis and  identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of PF. These are all very worthy studies and we encourage your participation.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the August edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

TSANZ Past President’s Award

The TSANZ Past Presidents Scholarship Award aims to support early career researchers (ECRs) who do not have the resources available to them via their institution or workplace to:

1)  Develop their presentation of research skills, and/or

2) Present their research at a national or international professional conference of their choice.

The Scholarship will cover

  • Airfares
  • Accommodation
  • Ground travel and transfers
  • Registration
  • Per Diem Daily Allowance in accordance with the ATO Reasonable Travel and Meal Allowance Guide

Up to a maximum of AUD 7000, with the amount to be paid dependent on the delivery of receipts for the expenses incurred above.

Additionally, the Scholarship will provide the awardee with support from a TSANZ Past President to review their presentation and provide feedback and professional development on research presentation skills. The Past President will be determined by TSANZ.

Please visit the TSANZ Awards Submissions Portal for more information.

Boeringer Ingelheim New Zealand Primary Care Grant

The Boehringer Ingelheim New Zealand Primary Care Grant aims to support research which will address the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.

Primary care can include general practice, allied health services, community health and community pharmacy.

The grant is valued at NZD 5000 and will support studies for one year only.

Please visit the TSANZ Awards Submissions Portal for more information.

CREATE Grant-in-Aid Funding Opportunity

In 2020, there is a CREATE Grant-in-Aid opportunity for the award of one or more grants valued at a total of $7,000 to assist new collaborative investigator led Pulmonary Fibrosis research within the group of CREATE Fellows. The objective of the CREATE Grant-in-Aid is to encourage new research which meets the aims of the CRE-PF and builds collaborations between CREATE Fellows drawn together through the CRE-PF.

Please visit the LFA Awards Submissions Portal for more information.

LFA Awards

Lung Foundation Australia and its partners are excited to announce the following Research Grants will be open to application from 1 September 2020. For more information visit: https://lungfoundation.com.au/research/awards-and-grants/apply-for-funding/

YEAR OPEN

YEAR UNDERTAKEN

Award 

Target area 

Value

Duration

Timeline

2020

2021

Lung Foundation Australia – Lizotte Family Grant for IPF Research 

IPF 

 $        5,000.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

2020

2021

Lung Foundation Australia – Ludwig Engel Grant-in-Aid for Physiological Respiratory Research

IPF 

 $        5,000.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

2020

2021

Lung Foundation Australia -Ivan Cash Grant-in-Aid For IPF Research

IPF 

 $        5,000.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

2020

2021

Lung Foundation Australia -Cochrane Airways Australia 
Scholarship

Systematic Review

$        2,500.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

 

LFA 2020 Research Grant recipients

 

Congratulations to the recipients of the Lung Foundation Australia 2020 Research Grants.

2019

2020

Lung Foundation Australia – Ellen Yates Memorial Grant in Aid for Lung Cancer Research

$20,000.00 

Edith Cowan University

Dr. Afaf Abed

2019

2020

Lung Foundation Australia – Deep Manchanda Fellowship in Lung Cancer Research

$   160,000.00 

The Garvan Institute of Medical Research

Dr. Venessa Chin

2019

2020

Lung Foundation Australia – Di Cox PhD Scholarship in IPF Research 

 $      45,000.00 

 University of Sydney

Dr. Laura Glenn

2019

2020

Lung Foundation Australia – Brian Eaton PhD Scholarship in IPF Research 

 $      45,000.00 

 University of Sydney

Dr. Matthew Parker

2019

2020

Lung Foundation Australia – Lizotte Family Grant for IPF Research

$        5,000.00 

Austin Health

Dr Yet Hong Khor

2019

2020

Lung Foundation Australia – Ludwig Engel Grant-in-Aid for Physiological Respiratory Research

$        5,000.00 

The Children’s Hospital at Westmead

Dr. Alexander Wong 

2019

2020

Lung Foundation Australia – Ivan Cash Grant-in-Aid For IPF Research

$        5,000.00 

RMIT University 

Dr. Paris Papagianis

2019

2020

Lung Foundation Australia – Cochrane Airways Australia 
Scholarship

$        2,500.00 

University of South Australia

Kelsey Sharrad

 

Australasian Severe Asthma Registry (ASAR) Annual Report 2019

 

TSANZ is excited to share the ASAR 2019 Annual Report with you!

In 2019, TSANZ in collaboration with the Australasian Severe Asthma Network (ASAN), successfully transitioned the Severe Asthma Web-based Database (SAWD) to ASAR – a Clinical Quality Registry (CQR). ASAR is now uniquely positioned to collect longitudinal data (10-year follow-up) on a well-characterised severe asthma cohort in Australia and New Zealand with the capability to add modules of specific interest, for example, the Australasian Benralizumab Registry.

To view the ASAR 2019 Annual Report please click here.

Respirology – Editor’s Choice 

Respirology Issue 25.7 July 2020

 

Sputum transcriptomics implicates increased p38 signalling activity in severe asthma

Katherine J. Baines, Michael Fricker, Vanessa M. McDonald, Jodie L. Simpson, Lisa G. Wood, Peter A.B. Warik, Heather E. Macdonald, Andrew Reid and Peter G. Gibson

 

The authorship team from Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia

DOI: 10.1111/resp.13749

 

Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study

Hye Yun Park, Danbee Kang, Hyun Lee, Sun Hye Shin, Minwoong Kang, Sunga Kong, Chin Kook Rhee, Juhee Cho and Kwang Ha Yoo

 

The Korean COPD And Outcomes Study Team. From left to right: (Top) Kwang Ha Yoo, Danbee Kang, Sun Hye Shin, (Bottom) Juhee Cho and Hye Yun Park

DOI: 10.1111/resp.13678

Respirology Issue 25.8 August 2020

 

Ventilation heterogeneity and oscillometry predict asthma control improvement following step-up inhaled therapy in uncontrolled asthma

Francesca S.M. Tang, Sandra Rutting, Catherine E. Farrow, Katrina O. Tonga, Joanna Watts, Jessica R. Dame-Carrol, Amy Bertolin, Gregory G. King, Cindy Thamrin and David G. Chapman

 

The Airway Physiology and Imaging Group from the Woolcock Institute of Medical Research in Sydney, Australia, as part of the overall research team. From left to right: Prof. Gregory King, Dr David Chapman, Dr Sandra Rutting, Dr Katrina Tonga and A/Prof. Cindy Thamrin.

DOI: 10.1111/resp.13772

 

Identification and definition of asthma–COPD overlap: The CanCOLD study

Miriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, Wan C. Tan, Pei Z. Li, Shawn D. Aaron, Andrea Benedetti, Kenneth R. Chapman, Brandie Walker, J. Mark Fitzgerald, Paul Hernandez, François Maltais, Darcy D. Marciniuk, Denis E. O’Donnell, Don D. Sin, Jean Bourbeau for The Cancold Collaborative Research Group and The Canadian Respiratory Research Network

 

The authorship team on behalf of the CanCOLD Collaborative Research Group and

the Canadian Respiratory Research Network. From top left to right bottom: Miriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, Wan Tan, Pei Li, Shawn Aaron, Andrea Benedetti, Kenneth Chapman, B Walker, Mark Fitzgerald, Paul Hernandez, François Maltais, Darcy Marciniuk, Denis O’Donnell, Don Sin, Jean Bourbeau

DOI: 10.1111/resp.13780

Invitations and surveys

BREATHE Study

Do you have asthma, emphysema, chronic bronchitis or bronchiectasis?

Do you live in an area affected by bushfires or bushfire smoke?

If yes to both, you may be eligible for the BREATHE study.

We are studying facemasks for prevention of smoke exposure

Find out more: https://kirby.unsw.edu.au/breathe

Please register your interest: https://www.surveymonkey.com/r/C96DXJN

Contact us: e.kpozehouen@unsw.edu.au

Ethics Approval: HC200477

CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

Dear Members of the Thoracic Society of Australia and New Zealand,

Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

https://www.surveymonkey.com/r/F38Q8K2

We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

 

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

Dear Colleagues,

We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

Caring for People with Intellectual Disability survey

Thank you for considering our invitation
A/Prof Nathan Wilson, Western Sydney University
Dr Peter Lewis, Western Sydney University
Ms Virginia Howie, Central Queensland University
Dr Melissa Desroches, University of Massachusetts, Dartmouth

Kind regards,
Virginia

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

 

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland
Professor of Physiotherapy, Monash University and Alfred Health
Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.05 – JUNE 2022

VOLUME 5.01 – FEBRUARY 2020

Research Roundup:

February 2020

.
 

Welcome Message

Welcome to the first Research Roundup of 2020. The Research Sub-Committee are currently working their way through reviewing the many award applications received in the last few months. 

The TSANZSRS20 is less than 2 months away. This year’s theme is “Transformative Strategies for Improving Global Lung Health”. Visit the conference website for the full program or to register now

For the first time, the TSANZ will be offering a Carer’s Grant as part of the TSANZ travel award program to assist members who have the primary care giver responsibility of a child to attend and participate in the TSANZ ASM.

We wish you all the best in your work and in preparation of your grant applications.

Enjoy the February edition of your research roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

TSANZ ASM Carer’s Grant

 

TSANZ is committed to inclusion and diversity in all that we do. The TSANZ ASM Carer’s Grant is provided, as part of the TSANZ travel award program, to support TSANZ members who have primary care giver responsibility of a child financial assistance to attend and participate in the TSANZ Annual Scientific Meeting. The grant must be utilised to fund additional care giving costs incurred directly as a result of the caregiver’s participation in the ASM. The grant must not be used for existing care costs or to cover the usual costs of attendance such as travel expenses and conference registration.

Selection process: If more applicants are received than funds available, the TSANZ will, in their absolute discretion, determine how the funds will be allocated. Priority will be given to applicants with children up to primary school age or children of any age with special needs.

Closing date: Friday 28 February 2020

Note: Receipts will not be required until money is claimed after the event.

For more information click here.

Respirology – Editor’s Choice 

Respirology Issue 25.2 February 2019

 

Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand

Lianne Parkin, Joshua Quon, Katrina Sharples, David Barson AND Jack Dummer

 

 

DOI: 10.1111/resp.13662

 

Improved diagnostic yield for lung nodules with digital tomosynthesis-corrected navigational bronchoscopy: Initial experience with a novel adjunct

Matt Aboudara, Lance Roller, Otis Rickman, Robert J. Lentz, Jasleen Pannu, Heidi Chen, ​​​​​​​Fabien Maldonado

 

Researchers from The Vanderbilt University Medical Center, Nashville, TN, and The Ohio State University Wexner Medical Center, Columbus, OH, USA. Left to Right:  Robert Lentz, M.D., Fabien Maldonado, M.D., Charla Walston, NP, Jasleen Pannu, M.D., Matt Aboudara, M.D., and Otis Rickman, D.O.  (Missing:  Lance Roller and Heidi Chen)

DOI: 10.1111/resp.13609

Workshops and Conferences

 

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 7.05 – JUNE 2022

VOLUME 4.010 – DECEMBER 2019

Research Roundup:

December 2019

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have three awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS 2020!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Editor’s Choice 

Respirology Issue 24.12 December 2019

 

Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD

Mette Reilev, Anton Pottegård, Jesper Lykkegaard, Jens Søndergaard, Truls S Ingebrigtsen and Jesper Hallas

 

 

DOI: 10.1111/resp.13620

Top row, from left to right: Mette Reilev, Jesper Hallas and Anton Pottegård, Clinical Pharmacology and Pharmacy, University of Southern Denmark

Bottom row, from left to right: Jesper Lykkegaard and Jens Søndergaard, The Research Unit for General Practice, University of Southern Denmark

Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial

Maree A. Milross, Amanda J. Piper, Tiffany J. Dwyer, Keith Wong, Scott C. Bell, Peter T.P. Bye and the Non-Invasive Ventilation Cystic Fibrosis (NIVCF) Study Group

Non-invasive ventilation in cystic fibrosis

DOI: 10.1111/resp.13604

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

 

Chronic Breathlessness

 

The Australian national Palliative Care Clinical Studies Collaborative (PaCCSC) is pleased to announce the publication of results from a recently completed multi-site, double-blind, randomised controlled trial that found that regular, sustained-release morphine had similar benefits and harms to placebo in this adequately powered trial at one week.

The manuscript is titled “Regular, sustained-release morphine for chronic breathlessness: a multi-centre, double-blind, randomised, placebo controlled trial”. Authored by David Currow and colleagues, the paper was published in Thorax 2019; 213681 (ahead of print). A copy of the paper is attached for your benefit.

 

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 7.05 – JUNE 2022

VOLUME 4.09 NOVEMBER 2019

Research Roundup:

November 2019

.
 

Welcome Message

We are now in the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Sub-committee is in full swing reviewing award applications, the SIG convenors are reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2020, we are expecting another large conference, having received approximately 440 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2020.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

Lund Foundation Australia Research Awards 

  • Cochrane Airways Australia Scholarship – extended to 15 November 2019

To download application documents, click here.

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

TSANZ Webinar Series

 

“Tracheostomy tubes and principles of management” with Gavin Fahey

Event Date: Thursday, 14th of November 2019

Time: 2:30pm AEDT

Duration: 45 minutes

A presentation covering anatomy and physiology, tube selection, principles of nursing and emergency management.

Only limited places available! Don’t miss out!

The presenter: Gavin Fahey

Gavin Fahey currently works as Senior Respiratory Clinical Nurse Consultant (CNC) at Northern Health (NH) leading a team of Respiratory CNCs who since 2018 have collectively contributed to acquisition and management of oxygen services across NH, development of a 4-bed Respiratory Care Unit caring for patients with severe respiratory failure, and improving lung mass services incorporating development of Victoria’s first Specialist Ambulatory Pleural Service. Gavin’s experience includes working within both the Victorian Respiratory Support Service and Tracheostomy and Management Service (Austin Health) utilising his experience and advanced understanding of tracheostomy and ventilation management within the acute and outpatients setting.

CLICK HERE to register! 

_______________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 24.11 November 2019

Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial

Steven McKinstry, Joseph Singer, Jan Pieter Baarsma, Mark Weatherall, Richard Beasley, James Fingleton

DOI: 10.1111/resp.13575

Nasal High Flow therapy in use

BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo

Rebecca L. Harper, Suzanne Maiolo, Rebekah J. Ward, Jemma Seyfang, Michaelia P. Cockshell, Claudine S. Bonder, Paul N. Reynolds

Putative mechanism of cell therapy upregulating BMPR2 in pulmonary vessels via release of exosomes

DOI: 10.1111/resp.13552

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

Dear TSANZ Members,

Lung Foundation Australia, with the support of nursing members of the Australia and New Zealand – Lung Cancer Nurse Forum, invite you to the next workshop in the series: Treatment Modalities and Management of a Stage 3 NSCLC Patient workshop, in Hobart on Friday 29 November 2019.

These workshops are open to nurses and allied health with an interest in working with and caring for people with lung cancer.

Date: Friday 29 November 2019

Time: 9:30am – 12:30pm

Location: Cancer Support Centre, Royal Hobart Hospital, 48 Liverpool St, Hobart TAS 7000

Program: Medical experts including nurses, medical oncology and radiation oncology specialists, and allied health professionals will discuss the management of a Stage III unresectable lung cancer patient.

More information about the agenda and speakers are coming soon. Please see our website for up to date information on this workshop.

Workshops are free to attend and you will be provided with a certificate for your hours of learning.

Register here

Please RSVP by Friday 22 November 2019. Registrations are essential for seating and catering purposes. For more information on the event, please visit our website here.

For further queries, please contact our information and support centre freecall on 1800 654 301 or email enquiries@lungfoundation.com.au.

We hope to see you on the day!

Kind Regards,

Lung Foundation Australia

 

                                                                                                                                                              

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X